Daphylloside
CAS No. 14260-99-2
Daphylloside( —— )
Catalog No. M30868 CAS No. 14260-99-2
Daphylloside, and asperuloside can be suggested as endoplasmic reticulum stress regulators.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 504 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDaphylloside
-
NoteResearch use only, not for human use.
-
Brief DescriptionDaphylloside, and asperuloside can be suggested as endoplasmic reticulum stress regulators.
-
DescriptionDaphylloside, and asperuloside can be suggested as endoplasmic reticulum stress regulators.
-
In VitroDaphylloside may show some antioxidant effects.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14260-99-2
-
Formula Weight446.4
-
Molecular FormulaC19H26O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Osteocalcin (37-49) ...
Osteocalcin (37-49), human is a peptide fragment of Osteocalcin. Osteocalcin (37-49), human has been used to detecte the intact human osteocalcin in HPLC purified plasma and peritoneal dialysate from patients with terminal renal insufficiency and in extracted human bone.
-
ABI-1968 PM
ABI-1968 PM is a derivative of ABI-1968, an apoptosis-stimulating agent and an inhibitor of viral replication.
-
Siplizumab
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
Cart
sales@molnova.com